• Published 2012

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents

@article{HyeonCheolGwon2012SixMonthV1,
  title={Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents},
  author={Hyeon-CheolGwon and Joo-YongHahn and Kyung WooPark and Young BinSong and In-HoChae and Do-SunLim and Kyoo-RokHan and Jin-HoChoi and Seung-HyukChoi and Hyun-JaeKang and Bon-KwonKoo and TaehoonAhn and Jung-HanYoon and Myung-HoJeong and Taek-JongHong and Woo-YoungChung and Young-JinChoi and Seung-HoHur and Hyuck-MoonKwon and Dong-WoonJeon and Byung-OkKim and Si-HoonPark and Nam-HoLee and Hui-KyungJeon and YangsooJang and Hyo-SooKim},
  journal={Circulation},
  year={2012}
}
Background—The optimal duration of dual antiplatelet therapy (DAPT) after implantation of drug-eluting coronary stents remains undetermined. We aimed to test whether 6-month DAPT would be noninferior to 12-month DAPT after implantation of drug-eluting stents. Methods and Results—We randomly assigned 1443 patients undergoing implantation of drug-eluting stents to receive 6- or 12-month DAPT (in a 1:1 ratio). The primary end point was a target vessel failure, defined as the composite of cardiac… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 23 CITATIONS

Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials

  • Clinical Research in Cardiology
  • 2015
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED